Creative Medical Technology (NASDAQ:CELZ) Share Price Passes Below 200-Day Moving Average – Here’s Why

Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) shares passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $3.40 and traded as low as $2.26. Creative Medical Technology shares last traded at $2.29, with a volume of 21,929 shares traded.

Creative Medical Technology Price Performance

The firm has a 50-day moving average of $3.17 and a 200 day moving average of $3.38. The stock has a market capitalization of $4.00 million, a price-to-earnings ratio of -0.60 and a beta of 1.76.

Hedge Funds Weigh In On Creative Medical Technology

A hedge fund recently raised its stake in Creative Medical Technology stock. Aaron Wealth Advisors LLC grew its position in Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) by 19.3% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,570 shares of the company’s stock after acquiring an additional 3,170 shares during the period. Aaron Wealth Advisors LLC owned about 1.45% of Creative Medical Technology worth $75,000 at the end of the most recent quarter. Institutional investors own 1.42% of the company’s stock.

About Creative Medical Technology

Creative Medical Technology Holdings, Inc, a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.